A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

Published:2007-07-17 Issue:2 Volume:134 Page:125-135
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Baur Martina,van Oosterom Allan T.,Diéras Véronique,Tubiana-Hulin Michele,Coombes R. Charles,Hatschek Thomas,Murawsky Michael,Klink-Alakl May,Hudec Marcus,Dittrich Christian

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-007-0259-0.pdf

Reference44 articles.

1. Alba E, Martin M, Ramos M, Adrover E, Balil A, Jara C, Barnadas A, Fernandez-Aramburo A, Sanchez-Rovira P, Amenedo M, Cosado A (2004) Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study. J Clin Oncol 22:2587–2593

2. Alexandre J, Bleuzen P, Bonneterre J, Sutherland W, Misset JL, Guastalla JP, Viens P, Faivre S, Chahine A, Spielman M, Bensmaiine A, Marty M, Mahjoubi M, Cvitkovic E (2000) Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients. J Clin Oncol 18:562–573

3. Alexopoulos CG, Rigatos G, Efremidids AP, Papacharalambous A, Alexopoulos A, Vassilomanolakis M, Patila E for the Hellenic Cooperative Interhospital Group in Oncology (He-CIGO) (1999) A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy. Cancer Chemother Pharmacol 44:253–258

4. Ando M, Watanabe T, Nagata K, Narabayashi M, Adachi I, Katsunata N (2001) Efficacy of docetaxel 60 mg/m² in patients with metastatic breast cancer according to the status of anthracycline resistance. J Clin Oncol 19:336–342

5. Bear HD, Anderson S, Brown A, Smith R, Mamounas E, Fisher B, Margolese R, Theroet H, Soran A, Wickerham DL, Wolmark N (2003) The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21:4165–4174

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipids and polymers in pharmaceutical technology: Lifelong companions;International Journal of Pharmaceutics;2019-03

2. Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions;Journal of Oncology Pharmacy Practice;2018-11-12

3. Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic;Molecular Pharmaceutics;2017-05-18

4. Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors;Journal of International Medical Research;2014-01-07

5. Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere®;PLoS ONE;2013-04-23